Millennium Management’s China Biologic Products Holdings CBPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-819,774
Closed -$97.1M – 7492
2021
Q1
$97.1M Buy
819,774
+229,264
+39% +$27.1M 0.07% 243
2020
Q4
$69.7M Buy
590,510
+326,636
+124% +$37.9M 0.05% 317
2020
Q3
$29.3M Buy
263,874
+128,402
+95% +$13.8M 0.04% 570
2020
Q2
$13.8M Sell
135,472
-12,094
-8% -$1.29M 0.02% 981
2020
Q1
$15.9M Buy
147,566
+127,382
+631% +$14.6M 0.04% 559
2019
Q4
$2.35M Buy
20,184
+13,484
+201% +$1.56M ﹤0.01% 2512
2019
Q3
$766K Sell
6,700
-8,853
-57% -$880K ﹤0.01% 3007
2019
Q2
$1.48M Buy
15,553
+6,845
+79% +$645K ﹤0.01% 2586
2019
Q1
$795K Buy
+8,708
New +$713K ﹤0.01% 3004
2018
Q1
– Sell
-33,176
Closed -$2.61M – 4383
2017
Q4
$2.61M Buy
33,176
+9,932
+43% +$826K ﹤0.01% 2116
2017
Q3
$2.14M Buy
23,244
+18,910
+436% +$1.82M ﹤0.01% 2128
2017
Q2
$490K Sell
4,334
-40,039
-90% -$4.47M ﹤0.01% 2812
2017
Q1
$4.44M Sell
44,373
-16,112
-27% -$1.72M 0.01% 1530
2016
Q4
$6.5M Buy
60,485
+168
+0.3% +$19.6K 0.01% 1160
2016
Q3
$7.51M Buy
60,317
+31,991
+113% +$3.78M 0.01% 1089
2016
Q2
$3.01M Buy
+28,326
New +$3.29M 0.01% 1561
2015
Q4
– Sell
-84,213
Closed -$7.56M – 3996
2015
Q3
$7.56M Buy
84,213
+37,416
+80% +$3.95M 0.01% 1095
2015
Q2
$5.39M Buy
+46,797
New +$4.92M 0.01% 1352
2015
Q1
– Sell
-39,658
Closed -$2.67M – 4399
2014
Q4
$2.67M Buy
39,658
+29,727
+299% +$1.84M 0.01% 1784
2014
Q3
$536K Buy
+9,931
New +$489K ﹤0.01% 2703

Millennium Management's CBPO Position: Q2 2021 in Review

Millennium Management sold out of China Biologic Products Holdings (CBPO) in Q2 2021, closing a stake of 819,774 shares — an estimated $97.1M sold.

Millennium Management first reported a position in CBPO in Q3 2014 and held it in 20 quarters. The position peaked at $97.1M in Q1 2021. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

  • Millennium Management reported no remaining China Biologic Products Holdings position as of Q2 2021 after selling out during the quarter.
  • Millennium Management sold 819,774 China Biologic Products Holdings shares in Q2 2021, an estimated $97.1M.
  • Millennium Management first reported a position in China Biologic Products Holdings in Q3 2014 and held it in 20 quarters.
  • Millennium Management's China Biologic Products Holdings position peaked at $97.1M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held China Biologic Products Holdings as of Q2 2021.

Based on Millennium Management's 13F filing for Q2 2021, filed 16 Aug 2021.